The Natco pharma has successfully completed with the US FDA audit of their Chennai based facility. The audit was done for the active pharmaceutical ingredient facility between 8 July-12 July 2019.
The audit of chennai based Natco pharma's facility ends with zero observations.
Natco Pharma is involved in business of research, development, manufacturing and marketing of finished dosage forms and pharmaceutical substances for International and Indian markets.
Mr Vinod Arora, Principal Advisor, IGMPI
Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like